Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

People with alopecia areata often have lower vitamin D levels than healthy people.

The document suggests there might be a link between Kawasaki Disease and Alopecia Areata that needs more research.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

The document says homoeopathic treatments are good for hair regrowth in alopecia areata but doesn't give proof.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

An 8-year-old girl had nail and hair issues that improved without specific treatment, but fungal nail infection was hard to cure.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Alopecia areata often starts around age 23, can be permanent in 30% of cases, and treatments are usually temporary.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Dermoscopy helps diagnose and manage alopecia areata by showing specific hair changes.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Baricitinib is effective and safe for treating severe alopecia areata.

Finding eosinophils near hair bulbs helps diagnose alopecia areata.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Apremilast was not effective in treating moderate-to-severe alopecia areata.